Abstract
Functional recovery of motor deficits post-stroke is improved with physical therapy, however functional recovery is often incomplete. Non-invasive brain stimulation may enhance functional recovery post-stroke. This systematic review explored the effectiveness of high-frequency repetitive Transcranial Magnetic Stimulation (HF-rTMS) to improve upper limb motor function post-stroke. A database search was conducted within PubMed, CINAHL, Embase and Cochrane Library. Criteria for inclusion: randomised controlled trials employing HF-rTMS on the affected hemisphere of adults post-stroke, and using the Fugl-Meyer Assessment (FMA) tool. The Cochrane Risk of Bias 2 tool and GRADE framework were applied. Sixteen articles were included in the review. There was significant improvement in FMA-UL scores immediately post-intervention (mean difference = 3.53 [95% CI 1.82 to 44.58]) and 1-3 months post-intervention (8.95 [5.95 to 11.95]) for patients who commenced treatment within 1-month of their stroke. Based on the FMA, excitatory rTMS may provide more favourable effects on motor recovery when applied in the first-month post-stroke, however a variety of heterogeneous application parameters limit the certainty of effectiveness.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This systematic review and meta analysis used data from the original manuscripts cited in this paper.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos